埃及、伊拉克、约旦和黎巴嫩的抗菌药物耐药格局与COVID-19影响:基于调查的研究与专家意见
该横断面问卷调查研究纳入埃及(n=82)、黎巴嫩(n=49)、伊拉克(n=43)、约旦(n=30)共204名医师,评估抗菌药物耐药(AMR)格局、抗菌药物管理(AMS)实施障碍及COVID-19影响。调查显示既往抗菌药物使用和既往细菌定植被视为AMR增加的最常见危险因素,耐多药革兰阴性菌最常见于下呼吸道感染,肺炎克雷伯菌和大肠埃希菌是医院获得性感染中最常检出的革兰阴性菌。仅14.8%儿科医师和28.6%成人医师报告医院开展目标病原体基因分型和表型检测,主要障碍为技术和资源限制。COVID-19期间四国AMR显著上升,与医院占用率增加、AMR监测优先级下降、AMR流行病学变化及大量不必要抗菌药物处方导致的药物短缺有关。作者据此提出行动呼吁,建议各国应对上述挑战。
要点
- 204名医师中仅14.8%儿科医师和28.6%成人医师报告医院开展目标病原体基因分型和表型检测,主要障碍为技术和资源限制。
- 耐多药革兰阴性菌最常见于下呼吸道感染,肺炎克雷伯菌和大肠埃希菌是医院获得性感染中最常检出的革兰阴性菌。
- COVID-19期间四国AMR显著上升,因素包括医院占用率增加、AMR监测优先级下降、AMR流行病学变化及大量不必要抗菌药物处方导致的药物短缺。
- 多数COVID-19患者就诊前已使用抗菌药物,入住ICU的COVID-19患者中多数检出耐多药革兰阴性菌。
- AMS实施主要障碍为缺乏受训的AMS人员、医护人员AMS知识与培训不足、财务限制及缺乏AMR监测系统,且AMS举措未标准化。
适用人群与场景
- 埃及、伊拉克、约旦和黎巴嫩的医师(共204名:埃及n=82、黎巴嫩n=49、伊拉克n=43、约旦n=30),涵盖儿科和成人医师。
处置流程与药物剂量
- 经验性抗菌治疗选择由抗菌药物的抗菌谱和安全性、感染部位、合并症以及已发表的指南和本地抗菌药物谱决定。
研究设计与关键结果
- 横断面问卷调查研究,共204名医师完成调查:埃及n=82、黎巴嫩n=49、伊拉克n=43、约旦n=30。
- 既往抗菌药物使用和既往细菌定植被视为AMR增加的最常见危险因素。
- 耐多药革兰阴性菌最常见于下呼吸道感染,肺炎克雷伯菌和大肠埃希菌是医院获得性感染中最常检出的革兰阴性菌。
- 仅14.8%儿科医师和28.6%成人医师报告医院开展目标病原体基因分型和表型检测,缺乏检测的最常见原因为技术和资源限制。
- 技术和资源限制以及新型抗菌药物的稀缺和高成本被认定为该地区成功管理耐多药革兰阴性菌感染的最显著障碍。
- COVID-19大流行期间四国AMR显著上升,因素包括医院占用率增加、优先级从AMR监测转移及AMR流行病学变化。
- COVID-19期间大量不必要和无依据的抗菌药物处方导致后续抗菌药物短缺和该地区AMR显著增加。
- 医师指出多数COVID-19患者就诊前已使用抗菌药物;入住ICU的COVID-19患者中多数检出耐多药革兰阴性菌。
证据类型、等级与局限
- 证据类型:横断面问卷调查研究与专家意见。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者基于调查结果提出行动呼吁,建议该地区各国采取措施应对AMR和AMS障碍。
- 调查提示经验性抗菌治疗选择需考虑抗菌药物的抗菌谱和安全性、感染部位、合并症以及已发表的指南和本地抗菌药物谱。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The objective of this study was to assess the antimicrobial resistance (AMR) landscape and the impact of COVID-19 on AMR in Egypt, Iraq, Jordan, and Lebanon, and to gather expert opinions on the barriers to the implementation of antimicrobial stewardship (AMS) initiatives in the region.
METHODS: A cross-sectional questionnaire survey was used to assess the current AMR landscape, existing AMS initiatives, barriers to implementing AMS initiatives, and the impact of COVID-19 on AMR in the four countries.
RESULTS: The survey was completed by 204 physicians from Egypt (n = 82), Lebanon (n = 49), Iraq (n = 43), and Jordan (n = 30). Previous antibiotic use and previous bacterial colonization were perceived as the most common risk factors for an increase in AMR. According to the survey, multidrug-resistant (MDR) gram-negative bacteria were most common in lower respiratory tract infections, and Klebsiella pneumoniae and Escherichia coli were the most commonly identified gram-negative bacteria in hospital-acquired infections. Only 14.8% of pediatric physicians and 28.6% of adult physicians reported that target pathogen genotyping and phenotyping were done in hospitals, and the most commonly reported reasons for the lack of testing were technological and resource constraints. These constraints, coupled with the scarcity and high cost of newer antibiotics, have been identified as the most significant barriers to the successful management of MDR gram-negative bacterial infections in the region. It was reported that the spectrum of activity and safety of the antibiotic, the site of infection, the presence of comorbidities, and published guidelines and local antibiograms determined the choice of empirical antibiotic therapy for patients in the region. The four countries experienced a significant rise in AMR due to several factors during the COVID-19 pandemic, including an increase in hospital occupancy, a shift in priorities away from AMR surveillance, and changes in AMR epidemiology. Additionally, the large volumes of unnecessary and unsubstantiated antibiotic prescriptions during the COVID-19 pandemic has led to subsequent antibiotic shortages and significant increases in AMR in the region. Physicians also noted that the majority of COVID-19 patients were already on antibiotics before visiting the healthcare facility. MDR gram-negative bacteria were found in the majority of COVID-19 patients admitted to the intensive care unit. Despite the fact that various AMS initiatives have been implemented, they are not standardized across the region. Some of the main barriers to AMS implementation in the region are a lack of adequately trained AMS staff, lack of AMS knowledge and training among healthcare professionals, financial constraints, and the lack of AMR surveillance systems.
CONCLUSION: These survey results provide valuable insights into the existing AMR and AMS landscape in the region, as well as the barriers that impede efficient AMS and AMR management. Based on these findings, the authors developed a call to action that suggests ways for each country in the region to address these challenges.
参考来源
- Bizri AR, El-Fattah AA, Bazaraa HM, et al. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion. PLoS One. 2023. PMID: 37498951. doi:10.1371/journal.pone.0288550
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。